APOE and atherosclerosis: These range from attenuating atherosclerosis in diabetic apolipoprotein (apoE) −/− mice [15], having no effect on AngII-induced atherosclerosis in apoE −/− mice [6], [12], to increased atherosclerosis in young apoE −/− female mice [6] or apoE and AT1a receptor double deficient mice [16].